IGF1R and Ewing sarcoma: Next generaration whole exome sequencing of patients with Ewing's sarcoma responding to IGF1R based treatment and reverse phase protein array analysis in patients acquiring resistance is underway and will help to decipher unidentified mechanisms and perhaps unravel novel mutations and genetic aberrations in the response and resistance pathways.